Literature DB >> 6135515

Dinitrotoluene structure-dependent initiation of hepatocytes in vivo.

T B Leonard, O Lyght, J A Popp.   

Abstract

Technical grade dinitrotoluene (TDNT), composed principally of 2,4-DNT (76%) and 2,6-DNT (20%), is a potent hepatocarcinogen when fed to male F-344 rats for 1 year (100% incidence of hepatocellular carcinoma) while 2,4-DNT is only weakly hepatocarcinogenic. The present investigation was designed to determine the relative initiating potential of DNT isomers compared with the initiating potential of TDNT. A single administration of either TDNT or 2,6-dinitrotoluene (75 mg/kg, p.o.), in combination with partial hepatectomy, initiated hepatocytes in rats when assayed using hepatic initiation-promotion protocols. Five other DNT isomers (2,3; 2,4; 2,5; 3,4, and 3,5-DNT) evaluated similarly exhibited no such potential. Although 2,6-DNT was a relatively weak initiator, its activity was comparable to the initiating activity detected in TDNT. These data begin to provide an explanation for the marked differences in the hepatocarcinogenic potency of TDNT and 2,4-DNT observed in independent 2 year bioassays.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135515     DOI: 10.1093/carcin/4.8.1059

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

1.  Modulation of DNA synthesis in aortic smooth muscle cells by dinitrotoluenes.

Authors:  K S Ramos; K K McMahon; C Alipui; D Demick
Journal:  Cell Biol Toxicol       Date:  1991-04       Impact factor: 6.691

2.  Comparison of DNA adduct formation between 2,4 and 2,6-dinitrotoluene by 32P-postlabelling analysis.

Authors:  D K La; J R Froines
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

3.  Cytotoxicity and expression of c-fos, HSP70, and GADD45/153 proteins in human liver carcinoma (HepG2) cells exposed to dinitrotoluenes.

Authors:  Konsuela Y Glass; Cecilia R Newsome; Paul B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2005-08       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.